15 October

Aptamer E-Conference 2020

We talked about the potential of aptamers, how they can increase the effectiveness of targeted apheresis, we discussed the portfolio of R&D projects in the aptamer sector and answered questions from guests.

The event was attended by the representatives of the Company:

  • dr. Przemysław Jurek – Director of Research & Development in Pure Biologics
  • dr. Ewelina Świderek – Scientific Manager of PB005 project
  • dr. Tomasz Bąkowski – Scientific Manager of PB002 project
  • dr. Filip Jeleń, MBA – Pure Biologics Founder, Chairman of the Board

and special guests:

  • prof. dr. hab. n. med Bogusław Paradowski – neurologist and surgeon with many years of experience in the field of neurodegenerative and autoimmune diseases, associated with the Medical University of Wroclaw.
  • prof. dr. hab. n. med. Konrad Rejdak – experienced neurologist, president of the Polish Neurological Society, associated with the Medical University of Lublin. Particularly involved in the development of the myasthenia gravis therapy.

Watch: 🎥 Video – Aptamer E-Conference 2020 (🇵🇱)


Menu Close

We use cookies to give you the best browsing experience, site traffic analysis, and advertisement management.

Pure Biologics - Harnessing the power of antibodies and aptamers